Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Forecasting Delayed Neurocognitive and Endocrine Toxicity from Radiation in Brain Tumor Patients

  • By

  • Kyle Tuohy

  • Aarav Badani

  • Ava Franklin

  • Brad Zacharia

  • Dawit Aregawi

  • Alireza Mansouri

  • Paul Brown

  • Michael Glantz

  • May 28, 2026

Share

Original Source(s)

Predicting late radiation-associated neurocognitive and endocrine toxicity in patients with brain tumors

  • by Kyle Tuohy, Aarav Badani, Ava Franklin, Brad Zacharia, Dawit Aregawi, Alireza Mansouri, Paul Brown, Michael Glantz

  • May 28, 2026

Related Content

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma

Intraoperative radiotherapy after resection of newly diagnosed brain metastases in adult patients - results of a prospective phase II trial (INTRAMET)

Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?